Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Corcept Therapeutics
CORT
$12.4B
| $1.08M | ﹤0.01% |
12,981
-46,381
| -78% | -$3.36M |
|
3277
iShares MSCI Australia ETF
EWA
$1.39B
| $1.07M | ﹤0.01% |
39,788
+11,578
| +41% | +$309K |
|
3278
HSBC
HSBC
$365B
| $1.07M | ﹤0.01% |
15,085
-42,543
| -74% | -$2.77M |
|
3279
TETRA Technologies
TTI
$1.14B
| $1.06M | ﹤0.01% |
185,064
-31,326
| -14% | -$134K |
|
3280
Bankwell Financial Group
BWFG
$543M
| $1.06M | ﹤0.01% |
24,040
+307
| +1% | +$12.6K |
|
3281
Citizens
CIA
$239M
| $1.06M | ﹤0.01% |
202,219
+56,188
| +38% | +$262K |
|
3282
Sabre
SABR
$731M
| $1.06M | ﹤0.01% |
579,248
-663,153
| -53% | -$1.56M |
|
3283
PUT
BridgeBio Pharma
BBIO
$15.7B
| $1.06M | ﹤0.01% |
+20,400
| New | +$995K |
|
3284
PUT
PENN Entertainment
PENN
$2.75B
| $1.06M | ﹤0.01% |
+55,000
| New | +$1.03M |
|
3285
iShares MSCI Taiwan ETF
EWT
$9.86B
| $1.06M | ﹤0.01% |
16,600
+13,615
| +456% | +$820K |
|
3286
i3 Verticals
IIIV
$412M
| $1.05M | ﹤0.01% |
32,485
-10,807
| -25% | -$326K |
|
|
RSVR
3287
DELISTED
Reservoir Media
RSVR
| $1.05M | ﹤0.01% |
129,426
+14,683
| +13% | +$115K |
|
3288
Vestis
VSTS
$1.91B
| $1.05M | ﹤0.01% |
232,398
-55,802
| -19% | -$286K |
|
3289
Alerus Financial
ALRS
$831M
| $1.05M | ﹤0.01% |
47,490
-4,939
| -9% | -$109K |
|
3290
PRA Group
PRAA
$663M
| $1.05M | ﹤0.01% |
68,087
-74,333
| -52% | -$1.2M |
|
3291
CALL
Biogen
BIIB
$30B
| $1.05M | ﹤0.01% |
+7,500
| New | +$1.01M |
|
3292
Karat Packaging
KRT
$803M
| $1.05M | ﹤0.01% |
41,664
-747
| -2% | -$19.6K |
|
3293
Climb Global Solutions
CLMB
$500M
| $1.05M | ﹤0.01% |
31,132
-5,196
| -14% | -$154K |
|
3294
Metropolitan Bank Holding Corp
MCB
$1.15B
| $1.05M | ﹤0.01% |
13,997
-10,777
| -44% | -$810K |
|
3295
Midland States Bancorp
MSBI
$699M
| $1.04M | ﹤0.01% |
60,917
-11,565
| -16% | -$208K |
|
3296
VanEck Pharmaceutical ETF
PPH
$959M
| $1.04M | ﹤0.01% |
+11,542
| New | +$1.01M |
|
3297
SmartFinancial
SMBK
$896M
| $1.04M | ﹤0.01% |
29,026
-1,361
| -4% | -$48.7K |
|
3298
First Community Bankshares
FCBC
$900M
| $1.04M | ﹤0.01% |
29,767
-6,720
| -18% | -$254K |
|
3299
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.12B
| $1.04M | ﹤0.01% |
3,700
| – | – |
|
3300
IBEX
IBEX
$473M
| $1.03M | ﹤0.01% |
25,536
-431
| -2% | -$13.7K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.